12.84 335.21 10.12 138.93 41.45 EPS (Baht per Share) * 0.50 0.35 0.15 42.86 Weighted Average Number of Ordinary Shares (Million Shares) * 947.96 947.96 - - Return on Equity (ROE) (%) 29.60% 20.78% 8.82

Company reported net loss attributable to the equity holder of the Company was 338.6 million baht. Loss per share for this quarter was 0.16 baht. Notable Event 1Q2020 Airline Business 1. The COVID-19

Purchaser also agreed to adjust the Enterprise Value by the amount of cash, interest-bearing liabilities and actual net working capital of the Targets as at the Completion Date under the terms and method

date for determining the underlying value: Guarantee/collateral: Method of redemption:  Physical  Cash  Physical or Cash  Etc. …… Principal protection at maturity date: Offering price: Condition for

-CS021/2017 Financial information as of 31 August 2017* : Total Assets 11,852,821.04 Baht Total Liabilities 20,351.79 Baht** Retained Earning (loss) (417,530.75) Baht Shareholders’ equity 11,832,469.25

derived from the method of calculation, whereby the calculation is based on the Company's reviewed consolidated financial statements for the 6-month period as of 30 June 2019. Therefore, the entering of

4,266 million or 17% mainly from recognition of long-term lease liabilities of THB 2,510 million and from recognition of derivatives liabilities of THB 2,215 million. Total Equity As of 30 June 2020

in skin cares and cosmetics. In addition, At-Ze distributed medical care products under brand name “Aesthetic Zecret”. Criterion Calculation Method Transaction size 1. Net tangible assets (NTA

Calculation Method Transaction size 1. Net tangible assets (NTA) Proportion of assets acquired (100%) x NTA AT-ZE (29.78) NTA WINNER (604.68) 4.93 % 2. Net income Proportion of assets acquired (100%) x Net

skin medicine under trademarks including trademark of “DERMALIS”, (which will be Criterion Calculation Method Transaction size 1. Net tangible assets (NTA) Proportion of assets acquired (100%) x NTA AT